Compare RNXT & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Recon Technology Ltd is an oilfield service company. The company is engaged in the sale of oilfield automation products, equipment for oil and gas production and transportation, and engineering services. It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. Majority of the firm's revenue comes from the Automation Product and Software segment.